N Shorts
World’s first lung cancer prevention vaccine trial receives £2.06 m funding
A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach trains the immune system to identify and eliminate early abnormal lung cells before they become tumours. Researchers are hopeful this preventative measure could significantly reduce lung cancer incidence and improve survival rates for those at high risk.

Technically enhanced content presented under fair use in public-interest journalism.

Listen:

↓ Download Audio


Discover more from Newz Quest

Subscribe to get the latest posts sent to your email.

By Vanshika

Meet Vanshika, a promising trainee at Newzquest.in, who plays a vital role in managing the news site’s operations with dedication and precision. With a strong interest in economics and data-driven insights, Vanshika focuses on analyzing economic trends to provide clear and timely news reporting. Her analytical mindset and eagerness to learn have made her an important contributor to the editorial process, enhancing content quality and aligning with the diverse expectations of Newzquest’s audience. Committed to continual growth, Vanshika actively deepens her understanding of the news landscape to offer nuanced insights on critical issues, helping foster a well-informed community.

Discover more from Newz Quest

Subscribe now to keep reading and get access to the full archive.

Continue reading